Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteins

Neuroscience Letters

Volumn 406, Issue 3, 2006, Pages 169-173

  Uustare, Ain ^a   Reinart, Reet ^a   Rinken, Ago ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Adenosine A1 receptor; Adenylate cyclase; Dopamine D1 receptor; G proteins; Receptor receptor interactions; Sf9 cell line

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE A1 RECEPTOR; ADENOSINE DERIVATIVE; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; N CYCLOPENTYLADENOSINE; TRITIUM; UNCLASSIFIED DRUG; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; GENETIC TRANSFECTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; ARMYWORM; BINDING COMPETITION; CELL LINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; RADIOASSAY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ADENOSINE; ANIMALS; BINDING, COMPETITIVE; CELL LINE; CYCLIC AMP; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A1; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION; SPODOPTERA; TRANSFECTION; TRITIUM; XANTHINES;

EID: 33748142843     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.07.051     Document Type: Article

References (27)

1. Dalpiaz A., Scatturin A., Menegatti E., Bortolotti F., Pavan B., Biondi C., Durini E., and Manfredini S. Synthesis and study of 5′-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist. Pharm. Res. 18 (2001) 531-536
2. 1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience 26 (1988) 83-100
3. Dong G.Z., Kameyama K., Rinken A., and Haga T. Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells. J. Pharmacol. Exp. Ther. 274 (1995) 378-384
4. Ferre S., Fuxe K., von Euler G., Johansson B., and Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience 51 (1992) 501-512
5. 1 receptor-mediated mechanisms. Eur. J. Neurosci. 8 (1996) 1545-1553
6. 1 receptors in stably cotransfected fibroblast cells. J. Biol. Chem. 273 (1998) 4718-4724
7. 2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer. Eur. J. Biochem. 270 (2003) 3928-3938
8. 1-receptor with Gsalpha proteins in Sf9 insect cells: limitations in comparison with fusion proteins. Biochim. Biophys. Acta 1613 (2003) 101-114
9. 1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8606-8611
10. 1 receptor. Acta Pharmacol. Sin. 24 (2003) 225-229
11. Herve D., Le Moine C., Corvol J.C., Belluscio L., Ledent C., Fienberg A.A., Jaber M., Studler J.M., and Girault J.A. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J. Neurosci. 21 (2001) 4390-4399
12. Järv J., Hedlund B., and Bartfai T. Isomerization of the muscarinic receptor * antagonist complex. J. Biol. Chem. 254 (1979) 5595-5598
13. 1B dopamine receptor desensitization. J. Neurochem. 82 (2002) 1549-1552
14. Lepiku M., Rinken A., Järv J., and Fuxe K. Kinetic evidence for isomerization of the dopamine receptor-raclopride complex. Neurochem. Int. 28 (1996) 591-595
15. 2A receptors. Neurosci. Lett. 239 (1997) 61-64
16. 1-like receptors expressed in Sf9 cells. Eur. J. Pharmacol. 420 (2001) 73-82
17. 1 receptor subtype. Mol. Pharmacol. 31 (1987) 247-252
18. Näsman J., Kukkonen J.P., and Åkerman K.E.O. Dual signalling by different octopamine receptors converges on adenylate cyclase in Sf9 cells. Insect. Biochem. Mol. Biol. 32 (2002) 285-293
19. Nasman J., Kukkonen J.P., Ammoun S., and Akerman K.E.O. Role of G-protein availability in differential signaling by alpha 2-adrenoceptors. Biochem. Pharmacol. 62 (2001) 913-922
20. Nordstedt C., and Fredholm B.B. A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal. Biochem. 189 (1990) 231-234
21. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
22. 1 receptors in cerebral cortex and neostriatum: evidence for heterogeneities in affinity states and cortical distribution. J. Neurochem. 50 (1988) 451-463
23. 2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. Eur. J. Pharmacol. 347 (1998) 153-158
24. Rinken A. Formation of the functional complexes of m2 muscarinic acetylcholine receptors with GTP-binding regulatory proteins in solution. J. Biochem. (Tokyo) 120 (1996) 193-200
25. Strickland S., Palmer G., and Massey V. Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction kinetic data. J. Biol. Chem. 250 (1975) 4048-4052
26. Uustare A., Nasman J., Akerman K.E., and Rinken A. Characterization of M2 muscarinic receptor activation of different G protein subtypes. Neurochem. Int. 44 (2004) 119-124
27. 2A receptors. Life Sci. 76 (2005) 1513-1526